Arvind Kush

Director/Board Member at INHIBIKASE THERAPEUTICS, INC.

Net worth: 294 350 $ as of 2026-06-29

43 year

5 connections

Consumer Services

Health Technology

Finance

Profile

Arvind Kush is currently an Independent Director at Inhibikase Therapeutics, Inc. since 2024 and Chief Financial & Business Officer at Candid Therapeutics, Inc. since 2014.
Formerly, Mr. Kush was Chief Financial & Accounting Officer at Rayzebio, Inc. from 2021 to 2024 and Managing Director-Healthcare Group at BofA Securities, Inc. from 2018 to 2021.
Education includes an undergraduate degree from Visvesvaraya Technological University and an MBA from Goizueta Business School-Emory.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
INHIBIKASE THERAPEUTICS, INC. 0.11%	2026-06-25	145,000 ( 0.11% )	294 350 $	2026-06-29

Arvind Kush active positions

Companies	Position	Start
INHIBIKASE THERAPEUTICS, INC.	Director/Board Member	2024-10-20

All active positions of Arvind Kush

Former positions of Arvind Kush

Companies	Position	End
RAYZEBIO, INC.	Director of Finance/CFO	2024-02-25
BofA Securities, Inc. BofA Securities, Inc. Investment Banks/BrokersFinance Provides brokerage services	Corporate Officer/Principal	2021-10-31

See the detail of Arvind Kush's experience

Training of Arvind Kush

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Arvind Kush's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
Visvesvaraya Technological University Visvesvaraya Technological University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Goizueta Business School-Emory Goizueta Business School-Emory Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Inhibikase Therapeutics, Inc. Inhibikase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small-molecule kinase inhibitor therapeutics for neurological diseases	Health Technology
BofA Securities, Inc. BofA Securities, Inc. Investment Banks/BrokersFinance Provides brokerage services	Finance
Rayzebio, Inc. Rayzebio, Inc. Pharmaceuticals: MajorHealth Technology Develops radiopharmaceutical therapeutics for cancer treatment	Health Technology